Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment ... for people living with hemophilia. In April, the FDA approved Pfizer’s Beqvez, a one-time gene therapy for ...

Pfizer’s Mylotarg ... after the FDA reapproved it in the aggressive blood cancer, acute myeloid leukaemia. The world’s first approved antibody-drug conjugate, where a targeted antibody ...

M.D., deputy director of the Division of Non-Malignant Hematology in the FDA’s Center for Drug Evaluation and Research. “This new treatment option highlights our continued efforts to improve the lives ...

the US Food and Drug Administration (FDA) approved fidanacogene elaparvovec (Beqvez), only the second gene therapy product for hemophilia B. Just a few months later, the Pfizer treatment ...

The anticlotting drug ... country’s regulatory body, the Food and Drug Administration (FDA). Eliquis is manufactured by Bristol-Myers Squibb (BMS) and will be marketed by BMS and Pfizer.

The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines ... has died Today in History: May 9, FDA approves first birth control pill Robert Prevost ...

April 21, 2025 – The FDA just approved the popular drug Dupixent ... said in a news release from Sanofi, the drug's maker. Developed by Sanofi and Regeneron and first approved in 2017 ...